Published Date: 30-Nov-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Fertility Supplements Market size is expected to reach $2.7 billion by 2028, rising at a market growth of 7.1% CAGR during the forecast period.
The Natural segment is showcasing a CAGR of 8.2% during (2022 - 2028). The increase can be attributed to shifting consumer attitudes toward the use of products containing organic and herbal ingredients as opposed to products that contain synthetic compounds. It is projected that the development of new products and technology advancements in the wellness and health industry will propel the expansion of the organic fertility supplement.
The Women segment acquired maximum revenue share the Global Fertility Supplements Market by End-use in 2021 thereby, achieving a market value of $1.6 billion by 2028. Many women between the ages of 15 and 49 who have not previously given birth struggle with infertility concerns. However, married infertile women were shown to have the highest incidence of reproductive problems. Awareness has increased owing to efforts made by the administration and non-profit groups to offer aid in the form of counseling and medical care.
The Prescribed segment has shown the growth rate of 6.5% during (2022 - 2028). It is anticipated that the demand for fertility supplements that are prescribed will increase as a result of stringent regulations imposed by the governmental bodies in certain regions. It is further being supported by a lack of certainty regarding the effectiveness of products that are not recommended by a healthcare practitioner, and less awareness on the part of individual consumers.
The Capsules segment dominated the Global Fertility Supplements Market by Product in 2021 thereby, achieving a market value of $871.5 million by 2028. A capsule form of pill encloses the drug it contains inside a shell. Powdered or fluid medication may be included within capsules, nevertheless, the efficacy of either formulation is identical. After entering the digestive tract, the capsule bursts open, and the active chemicals are then processed by the liver before being distributed throughout the body via the bloodstream.
The North America market dominated the Global Fertility Supplements Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1 billion by 2028. The Europe market is exhibiting a CAGR of 6.7% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 7.9% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fairhaven Health, Coast Science LLC, LENUS Pharma GesmbH, CellOxess LLC, Orthomol pharmazeutische Vertriebs GmbH, Exeltis USA, Inc. (Grupo INSUD), Yad-Tech, Bionova Lifesciences (Pragati Biocare Pvt. Ltd.), Vitabiotics Ltd., and TTK Healthcare Limited.
By Distribution Channel
Unique Offerings from KBV Research